HomeCOGT • NASDAQ
add
Cogent Biosciences Inc
Previous close
$38.34
Day range
$36.79 - $38.36
Year range
$3.72 - $43.73
Market cap
6.06B USD
Avg Volume
1.98M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 99.49M | 34.94% |
Net income | -102.49M | -50.89% |
Net profit margin | — | — |
Earnings per share | -0.56 | -525.33% |
EBITDA | -98.86M | -35.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 900.76M | 213.77% |
Total assets | 937.61M | 185.94% |
Total liabilities | 301.24M | 320.65% |
Total equity | 636.37M | — |
Shares outstanding | 161.05M | — |
Price to book | 11.28 | — |
Return on assets | -36.48% | — |
Return on capital | -40.18% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -102.49M | -50.89% |
Cash from operations | -79.10M | -30.59% |
Cash from investing | -322.77M | -623.37% |
Cash from financing | 588.67M | 2,264,011.54% |
Net change in cash | 186.80M | 16,578.12% |
Free cash flow | -48.04M | -34.03% |
About
Founded
2014
Headquarters
Website
Employees
258
